<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00282360</url>
  </required_header>
  <id_info>
    <org_study_id>SR05-1-5</org_study_id>
    <nct_id>NCT00282360</nct_id>
  </id_info>
  <brief_title>Effect of Metabolic Therapy in Patients With Chronic Ischemic Heart Disease</brief_title>
  <official_title>Effect of Metabolic Therapy in Patients With Chronic Ischemic Heart Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>IRCCS San Raffaele</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>IRCCS San Raffaele</source>
  <brief_summary>
    <textblock>
      Patients with coronary artery disease have an abnormal cardiac metabolism. The hypothesis of
      this study is that shifting cardiac metabolism from free fatty acids to glucose will improve
      myocardial ischemia
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The present study will evaluate the effect of free fatty acid inhibition with Trimetazidine
      on silent myocardial ischemia and total ischemic burden in coronary artery disease patients
      with type II diabetes.

      Patients will undergo ambulatory ECG monitoring at baseline and will be randomized to receive
      on top of thei standard anti-anginal therapy trimetazidine or placebo for 6 months. Patients
      will repeat the ambulatory ECG monitoring at the end of the study
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 1999</start_date>
  <completion_date>October 2003</completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>total ischemic burden</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>silent ischemia</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>symptomatic myocardial ischemia</measure>
  </secondary_outcome>
  <enrollment>30</enrollment>
  <condition>Coronary Artery Disease</condition>
  <condition>Type II Diabetes Mellitus</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Trimetazidine</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        coronary artery disease type II diabetes mellitus -

        Exclusion Criteria:

        unstable coronary artery syndromes impaired liver and kidney function
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Giuseppe Marazzi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>H San Raffaele EUR</affiliation>
  </overall_official>
  <verification_date>May 2004</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 24, 2006</study_first_submitted>
  <study_first_submitted_qc>January 24, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 26, 2006</study_first_posted>
  <last_update_submitted>January 24, 2006</last_update_submitted>
  <last_update_submitted_qc>January 24, 2006</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 26, 2006</last_update_posted>
  <keyword>coronary artery disease</keyword>
  <keyword>diabetes mellitus</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Trimetazidine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

